Sermorelin tells the body to make its own growth hormone — here is what the studies measured.

The short version

Sermorelin is a small lab-made peptide — a short chain of amino acids (the building blocks of proteins). It copies the first 29 pieces of a natural hormone your brain makes called GHRH (growth hormone-releasing hormone), the signal that tells your pituitary gland to release growth hormone (GH). So sermorelin is not growth hormone itself. It is the message that asks the body to make its own, in the body's own natural rhythm. Researchers have studied it for decades — first in children who were not growing normally, then in older adults whose GH output had dropped with age. People today mostly ask about it for body composition: less fat, more lean muscle. The honest picture: the clearest human results are in children and in short studies of GH and IGF-1 levels. Most of the body-fat data come from a close relative of sermorelin, not sermorelin itself. What people report — including the downsides and what to watch for — is on the effects page.

What sermorelin actually does in the body

Sermorelin works one step upstream of growth hormone. It binds the GHRH receptor (a docking site on the hormone-making cells of the pituitary gland) and switches on a chemical relay inside the cell — the cAMP/PKA pathway — that prompts those cells to release a pulse of growth hormone ^[1]. Because it nudges your own gland rather than pouring in outside hormone, the body's natural brakes still work: a second hormone called somatostatin and the downstream hormone IGF-1 (insulin-like growth factor 1, the messenger that carries out many of GH's effects) can still dial the signal back down ^[6]. That is the central appeal in the research literature — it aims to restore a pulse, the natural on-off rhythm of GH release, rather than flatten it.

The direct human evidence is strongest where the studies are oldest. In growth-hormone-deficient children, once-daily sermorelin injections roughly doubled first-year growth speed, from about 4.1 cm/year toward 7-8 cm/year, without pushing IGF-1 to excessive levels ^[2]. In healthy older men around 68 years old, two weeks of twice-daily GHRH(1-29) raised 24-hour GH and IGF-1 in a dose-related way, and at the higher dose their GH and IGF-1 numbers were no longer different from those of young men ^[3].

The body-composition angle, told honestly

Body composition is where the marketing and the evidence drift apart, so this site keeps them separate. Growth hormone genuinely shapes fat and muscle: its natural pulses help drive the breakdown of stored fat (lipolysis) in fasting humans ^[11]. And in older adults, a stabilized GHRH analog called tesamorelin — a close chemical cousin of sermorelin in the same drug class — cut percent body fat by about 7.4% over 20 weeks while raising IGF-1 by 117% within the normal range ^[7]. A separate randomized trial in adults with obesity and blunted GH found that the same GHRH-analog approach produced measurable changes in body composition ^[8].

The catch is that those fat-loss numbers come from tesamorelin and other analogs, not from controlled trials of sermorelin itself for fat loss in healthy adults ^[10]. So this is the line we hold throughout: the mechanism is real and the analog data are real, but using sermorelin for adult body composition or anti-aging is off-label and study-attributed, not a proven, approved outcome. The full picture is on the sermorelin weight loss page and the sermorelin before and after page.

Where sermorelin stands today

Sermorelin has real regulatory history. It was once an FDA-approved injectable medicine, used to help diagnose and treat growth-hormone deficiency in children. It was pulled from the U.S. market in 2008 for business reasons — not because it was found unsafe or ineffective ^[6]. Today it is most often prepared by compounding pharmacies, and the FDA treats it as a long-standing Category 1 bulk drug substance under its interim 503A compounding policy, with final guidance issued in January 2025.

It is also worth knowing what sermorelin is not approved to do. There is no FDA approval for anti-aging, fat loss, or muscle building, and an Annals of Internal Medicine editorial concluded that using GH-releasing agents to fight aging is 'not yet ready for prime time' ^[5]. We summarize what the studies found; we do not give doses or medical advice. Start with the Sermorelin research, see what people report on the Sermorelin effects page, or check the Sermorelin references.